SYNERGISTIC INTERACTION OF EPINEPHRINE AND CALCIUM IONOPHORE IN PLATELET AGGREGATION
Abstract
Background: Platelets play a key role in haemostasis. Human Platelets contain a2 adrenergic receptors, which are coupled with guanine nucleotide proteins (G proteins). The platelet activation involves a number of receptors for agonists. It has also been shown that most of the agonists act in synergy and potentiate the effects of each other. The present experimental study was designed to study the potentiation of epinephrine on human platelets by calcium ionophore A23187 and the possible role of calcium in platelet aggregation as a second messenger. Methods: Study was carried out at Department of Biological Sciences Aga Khan University, Karachi. Blood samples from healthy volunteers were collected; Platelet aggregation was measured using Dual channel Lumi Aggregometer. The chemicals used include epinephrine, calcium ionophore A23187, yohimbine, diltiazem, verapamil and S Nitrosoacetylpenicillamin (SNAP).Results: Epinephrine at low concentrations (0.01 - 0.2 mM) and/or A23187 (0.1-0.5 mM) itself did not produce platelet aggregation. However, when added together, a marked potentiation of platelet aggregation was observed. This synergistic effect was inhibited by a2-receptor blocker yohimbine; (IC50 = 0.05 mM) showing that the response is receptor mediated. To find out the molecular basis of this potentiation, we used SNAP, a nitric oxide donor and Ca++ channel blockers,i.e. diltiazem and verapamil. The SNAP, diltiazem and verapamil inhibited the platelet aggregation induced by A23187 and epinephrine with IC50 value of 0.5 mM, 50mM and 22mM respectively. Conclusion: The results of the study suggest that epinephrine and calcium ionophore act synergistically and Ca++ plays an important role in this synergistic interaction. While calcium channels blocking drugs diltiazem and verapamil inhibit this synergism.Key Words: Platelet aggregation, Epinephrine, calcium ionophore A23187, yohimbine, diltiazem, verapamil and SNAP.References
Siess W. Molecular mechanism of platelet activation. Physiol Rev 1989;69:58-178.
Grant JA, Scrutton MC. Novel α2 adrenoceptors primarily responsible for inducing human platelet aggregation. Nature 1979;277:659-61.
Homcy CJ. Garham RM. Molecular characterization of adrenergic receptors. Circ Res 1985:635-650.
Aktories K, Jakobs H. Eipnephrine inhibits adenylate cyclase and stimulates a GTPase in human platelet membrances via alpha-adrenoceptors. FEBS lett 1981;130: 235-38.
Connolly TM, Limibird LE. The influence of Na+ on the alpha adrenergic receptor system of human platelets. A method for removal of extraplatelet Na+: Effects of Na+ removal on aggregation secretion and cAMP accumulation. J Biol Chem 1983;258:3907-12.
Steen VM, Tysnes OB, Holmsen H. Synergism between thrombin and adrenaline (epinephrine) in human platelets Marked potentitation of inositol phospholipids metabolism. Biochem J 1988;253:581-6.
Steen VM, Cook CA, Tynes OB, Holmsen H. Potentiation by adrenaline of thrombin induced elevation of pH, is not essential for synergistic activation of human platelets. FEBS Lett 1989;250:211-7.
Banga HS, Somins ER, Brass LF, Rittenhouse SE. Activation of phospholipase A and C in human platelets exposed to epinephrine: role of glycoprotein II b/III a and dual role of epinephrine. Proc Natl Acad Aci USA 1986;83:9197-9201.
Steen VM, Holmsen H, Aarbakke G. The platelet stimulating effect of adrenaline through agonist. Thromb Haemost 1993;70(3):506-13.
Razi MS, Butt IF, Ayub M, Aslam M, Hameed W, Badar A, et al. Synergistic Interaction of Adenosine diphosphate-Epinephrine and Epinephrine- Collagen in aggregation of Human Platelets. J Ayub Med Coll Abbottabad 2004;16(3):20-24.
Ware JA, Smith M, Salzman EW. Synergism of platelet aggregating agents: Role of elevation of cytoplasmic calcium. J Clin Invest 1987; 80:267-71.
Shah BH, Siddiqui A, Qureshi KA, Khan M, Rafi S, Ujan VA et al. Coactivation of Gi and Gq proteins exerts synergistic effect on human platelet aggregation through activation of phosphlipase c and Ca ++ signaling pathways. Exp Mol Med 1999;31:42-46.
Grant J A, Scrutton MC. Positive interaction between agonists in the aggregation response of human blood platelets: Interaction between ADP, adrenaline and vasopressin. Br J Haematol 1980;44:109-125.
Steen VM, Holmsen H. Synergism between thrombin and epinephrine in human platelets: Different dose-response relationship for aggregation and dense granule secretion. Thromb Haemost 1985; 30:680-9.
Packham MA, Guccione MA, Chang PL, Mustard JF. Platelet aggregation and release; effects of low concentrations of thrombin or collagen. Am J Physiol 1973; 225:38-47.
Figures WR, Scearce LM, Wachtfogel Y, Chen J, Colman RF, Colman RW. Platelet ADP receptor and α2 adrenorceptor interaction. J Biol Chen 1986; 261:5981-5986.
Sation M, Salzman EW, Smith H, Ware JA. Activation of ptorein kinase C in platelets by epinephrine and A23187; Correlation with fibrinogen. Blood 1989;74:2001-7.
Kinlough-Rathbone RL, Mustard JF. Synergism of agonists. In Platelet Response and Metabolism. Holmser H; editor CRB Press, Boca Ration E.L 1986;193-207.
Born GVR. Adenosine diphosphate as a mediator of platelet aggregation in vivo; an editorial view. Circulation 1985;72(4):741-6.
Clapham DE, Neer EJ. G Protein βγ subunits. Ann Rev Pharmacol Toxicol 1997;37:167-203.
Banno Y, Asano T, Nozawa Y. Stimulation by G Protein βγ sub units of phopholipase C isoforms in human platelets. Thromb Haemost 1998;79:1008-1013.
Berridge MJ. Inositol trisphosphate and calcium signaling Nature 1993;361: 315-325.
Hemskerk JWM, Sage O. Calcium signaling in platelets and other cells. Platelets 1994;5:295-316.
Wang GR, Zhu Y, Haluskha PV, Lincoln TM, Mendelsohn ME. Mechanism of platelet inhibiton by nitric oxide: in vivo phosphorylation of thromboxane receptor by cyclic GMP-dependent protein kinase. Proc Natl Acad Sci USA 1998; 95: 4888-4893.
Wang X, Yanagi S, Yang C, Inatome R, Yamunura H. Tyrosine phosphorylation and SYK activation are involved in thrombin induced aggregation of epinephrine-potentiated platelets. JBiochemist 1997;121:322-330.
Nieswandt B, Bergmeier W, Eckly A, Schutle V, Ohlmann P, Cazenave JP, Ziringibl H et al. Evidence for cross cross talk between gloycoprotein VI and Gi coupled receptors during collagen induced platelet aggregation. Blood 2001;97 (12); 3829-3825.
Butt I F, Saeed S A, Rasheed H, Aslam M. Role of Phosphatidyl Inositol 3 Kinase in Epinephrine and Calcium Iononophore A 23187 induced Platelet Aggregation. Pak Armed Forces Med J 2004; 54 (1): 86-91.
Issue
Section
License
Journal of Ayub Medical College, Abbottabad is an OPEN ACCESS JOURNAL which means that all content is FREELY available without charge to all users whether registered with the journal or not. The work published by J Ayub Med Coll Abbottabad is licensed and distributed under the creative commons License CC BY ND Attribution-NoDerivs. Material printed in this journal is OPEN to access, and are FREE for use in academic and research work with proper citation. J Ayub Med Coll Abbottabad accepts only original material for publication with the understanding that except for abstracts, no part of the data has been published or will be submitted for publication elsewhere before appearing in J Ayub Med Coll Abbottabad. The Editorial Board of J Ayub Med Coll Abbottabad makes every effort to ensure the accuracy and authenticity of material printed in J Ayub Med Coll Abbottabad. However, conclusions and statements expressed are views of the authors and do not reflect the opinion/policy of J Ayub Med Coll Abbottabad or the Editorial Board.
USERS are allowed to read, download, copy, distribute, print, search, or link to the full texts of the articles, or use them for any other lawful purpose, without asking prior permission from the publisher or the author. This is in accordance with the BOAI definition of open access.
AUTHORS retain the rights of free downloading/unlimited e-print of full text and sharing/disseminating the article without any restriction, by any means including twitter, scholarly collaboration networks such as ResearchGate, Academia.eu, and social media sites such as Twitter, LinkedIn, Google Scholar and any other professional or academic networking site.
